Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carole A Long

Showing results (11-20 of 204) with videos related to

Pageof 21
Sort By:
Infection and Immunity|October 11, 2017
Evaluation of a Plasmodium-Specific Carrier Protein To Enhance Production of Recombinant <i>Pf</i>s25, a Leading Transmission-Blocking Vaccine CandidateElizabeth M Parzych, Kazutoyo Miura, Aarti Ramanathan, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2011
Evidence for erythrocyte-binding antigen 175 as a component of a ligand-blocking blood-stage malaria vaccineLubin Jiang, Deepak Gaur, Jianbing Mu, et al.
Infection and Immunity|January 27, 2004
Members of the merozoite surface protein 7 family with similar expression patterns differ in ability to protect against Plasmodium yoelii malariaKerrianne Mello, Thomas M Daly, Carole A Long, et al.
Malaria Journal|August 10, 2007
Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titerKazutoyo Miura, David B Keister, Olga V Muratova, et al.
Eukaryotic Cell|December 13, 2002
A multigene family that interacts with the amino terminus of plasmodium MSP-1 identified using the yeast two-hybrid systemKerrianne Mello, Thomas M Daly, Joanne Morrisey, et al.
Infection and Immunity|May 16, 2012
Evaluation of the immunogenicity and vaccine potential of recombinant Plasmodium falciparum merozoite surface protein 8James R Alaro, Evelina Angov, Ana M Lopez, et al.
Vaccine|December 7, 2007
Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccinesKazutoyo Miura, Andrew C Orcutt, Olga V Muratova, et al.
Infection and Immunity|November 26, 2003
Biochemical and immunological characterization of bacterially expressed and refolded Plasmodium falciparum 42-kilodalton C-terminal merozoite surface protein 1Sanjay Singh, Michael C Kennedy, Carole A Long, et al.
Vaccine|November 22, 2021
Immunogenicity of full-length P. vivax rPvs48/45 protein formulations in BALB/c miceMyriam Arévalo-Herrera, Kazutoyo Miura, Eduardo Solano, et al.
Infection and Immunity|November 20, 2002
Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malariaAnthony W Stowers, Michael C Kennedy, Brian P Keegan, et al.
Pageof 21

Showing results (11-20 of 204) with videos related to

Sort By:
Pageof 21
Infection and Immunity|October 11, 2017
Evaluation of a Plasmodium-Specific Carrier Protein To Enhance Production of Recombinant <i>Pf</i>s25, a Leading Transmission-Blocking Vaccine CandidateElizabeth M Parzych, Kazutoyo Miura, Aarti Ramanathan, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2011
Evidence for erythrocyte-binding antigen 175 as a component of a ligand-blocking blood-stage malaria vaccineLubin Jiang, Deepak Gaur, Jianbing Mu, et al.
Infection and Immunity|January 27, 2004
Members of the merozoite surface protein 7 family with similar expression patterns differ in ability to protect against Plasmodium yoelii malariaKerrianne Mello, Thomas M Daly, Carole A Long, et al.
Malaria Journal|August 10, 2007
Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titerKazutoyo Miura, David B Keister, Olga V Muratova, et al.
Eukaryotic Cell|December 13, 2002
A multigene family that interacts with the amino terminus of plasmodium MSP-1 identified using the yeast two-hybrid systemKerrianne Mello, Thomas M Daly, Joanne Morrisey, et al.
Infection and Immunity|May 16, 2012
Evaluation of the immunogenicity and vaccine potential of recombinant Plasmodium falciparum merozoite surface protein 8James R Alaro, Evelina Angov, Ana M Lopez, et al.
Vaccine|December 7, 2007
Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccinesKazutoyo Miura, Andrew C Orcutt, Olga V Muratova, et al.
Infection and Immunity|November 26, 2003
Biochemical and immunological characterization of bacterially expressed and refolded Plasmodium falciparum 42-kilodalton C-terminal merozoite surface protein 1Sanjay Singh, Michael C Kennedy, Carole A Long, et al.
Vaccine|November 22, 2021
Immunogenicity of full-length P. vivax rPvs48/45 protein formulations in BALB/c miceMyriam Arévalo-Herrera, Kazutoyo Miura, Eduardo Solano, et al.
Infection and Immunity|November 20, 2002
Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malariaAnthony W Stowers, Michael C Kennedy, Brian P Keegan, et al.
Pageof 21